GH1 and myocardial infarction: Significant evidence favoring the inhibitory effects of GH on norepinephrine release stems from an experimental study in rats, where GH-treatment early post-MI not only improved myocardial energy reserve, but also markedly decreased myocardial norepinephrine content and plasma levels [30].